Sign in

CIK 0001370053

  • Non-accelerated filer
  • Smaller reporting company

ANAPTYSBIO, INC

Sign in to watch
Ticker
ANAB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Jun 30
Incorporated
DE
Entity type
Operating
EIN
203828755
Phone
+1 858-362-6295
Business address
10770 WATERIDGE CIRCLE, SUITE 210, SAN DIEGO, CA, 92121
Former names
ANAPTYSBIO INC, ANAPTYS BIOSCIENCES INC
  1. 4 Planned sale CHIEF FINANCIAL OFFICER sold 1,500 shares at $23.72 ($35,580)
  2. 4 Open-market sale CEO sold 148,940 shares at an average $22.76 ($3,389,452)
  3. 4 Planned sale CHIEF LEGAL OFFICER sold 5,000 shares at $25.00 ($125,000)
  4. 4 Open-market sale CHIEF FINANCIAL OFFICER sold 3,065 shares at $23.63 ($72,425)
  5. 4 Open-market sale Chief Medical Officer sold 2,554 shares at $21.81 ($55,703)
  6. 4 Open-market sale Chief Legal Officer sold 2,305 shares at $21.81 ($50,272)
  7. 4 Open-market sale Chief Financial Officer sold 2,180 shares at $21.81 ($47,546)
  8. 4 Open-market sale CEO sold 6,866 shares at $21.81 ($149,747)
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Open-market sale Chief Legal Officer sold 882 shares at $14.19 ($12,516)

Page 6 of 15 · 298 filings